PAIN ANALGESIC RESPONSE IN OPIATE DEPENDENCE
阿片依赖的疼痛镇痛反应
基本信息
- 批准号:6515826
- 负责人:
- 金额:$ 53.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-06-01 至 2004-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: (Applicant's Abstract)
There is an increasingly large population receiving opiates on a chronic basis,
either for treatment of opiate dependence or for treatment of chronic pain.
Managing pain in opiate maintained individuals is a challenging problem. The
development of opioid tolerance and dependence may result in altered pain
sensitivity and subsequent response to additional opioids. Many clinicians
believe addicts cannot benefit from further opiate administration because they
are tolerant to the analgesic effects. Others believe that if an addict is
maintained on an opiate agonist, that medication provides adequate analgesia
for acute pain. Patients are reluctant to give accurate histories because
clinicians often withhold opioid analgesics from patients with a history of
drug abuse. Those who do complain are viewed suspiciously and their complaints
ignored. Currently there are few guidelines to assist clinicians and those that
do exist are based on experience and consensus rather than evidence-based
research.
This study proposes to examine: 1) how patients on opiate maintenance (either
buprenorphine or methadone) experience pain (tolerance and threshold) and how
they are different from non-opiate dependent individuals, 2) how patients
maintained on methadone and buprenorphine differ from normal controls in
response to added opiate and non-opiate analgesics and 3) how therapeutic
plasma concentration levels of morphine for analgesia differ in methadone and
buprenorphine maintained patients compared to normal controls.
The results of this proposed study will help develop systematic guidelines for
clinicians in the management of pain in opiate maintained individuals.
描述:(申请人摘要)
越来越多的人长期接受阿片类药物,
用于治疗阿片依赖或治疗慢性疼痛。
管理阿片类药物维持者的疼痛是一个具有挑战性的问题。这
阿片类药物耐受性和依赖性的发展可能会导致疼痛改变
对其他阿片类药物的敏感性和随后的反应。许多临床医生
相信成瘾者无法从进一步的阿片类药物管理中受益,因为他们
对镇痛作用具有耐受性。其他人则认为,如果一个瘾君子
维持阿片激动剂,药物提供足够的镇痛作用
用于急性疼痛。患者不愿意提供准确的病史,因为
临床医生经常不对有阿片类镇痛病史的患者使用阿片类镇痛药。
药物滥用。那些确实抱怨的人会受到怀疑,他们的抱怨
被忽略。目前,很少有指南可以帮助临床医生和那些
确实存在基于经验和共识,而不是基于证据
研究。
本研究旨在检查:1)患者如何维持阿片类药物(无论是
丁丙诺啡或美沙酮)经历疼痛(耐受性和阈值)以及如何
他们与非阿片类药物依赖者不同,2) 患者如何
维持美沙酮和丁丙诺啡与正常对照不同
对添加阿片类和非阿片类镇痛药的反应以及 3) 治疗效果如何
用于镇痛的吗啡血浆浓度水平在美沙酮和
丁丙诺啡维持患者与正常对照相比。
这项拟议研究的结果将有助于制定系统的指导方针
临床医生对阿片类药物维持个体的疼痛进行管理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WALTER NMN LING其他文献
WALTER NMN LING的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WALTER NMN LING', 18)}}的其他基金
Sustained-Release Methylphenidate For Management of Methamphetamine Use Disorders
缓释哌甲酯用于治疗甲基苯丙胺使用障碍
- 批准号:
7762850 - 财政年份:2009
- 资助金额:
$ 53.04万 - 项目类别:
Sustained-Release Methylphenidate For Management of Methamphetamine Use Disorders
缓释哌甲酯用于治疗甲基苯丙胺使用障碍
- 批准号:
7508842 - 财政年份:2009
- 资助金额:
$ 53.04万 - 项目类别:
Sustained-Release Methylphenidate For Management of Methamphetamine Use Disorders
缓释哌甲酯用于治疗甲基苯丙胺使用障碍
- 批准号:
8250473 - 财政年份:2009
- 资助金额:
$ 53.04万 - 项目类别:
Sustained-Release Methylphenidate For Management of Methamphetamine Use Disorders
缓释哌甲酯用于治疗甲基苯丙胺使用障碍
- 批准号:
8069996 - 财政年份:2009
- 资助金额:
$ 53.04万 - 项目类别:
Optimizing Outcomes Using Suboxone for Opiate Dependence
使用 Suboxone 优化阿片类药物依赖的结果
- 批准号:
7284221 - 财政年份:2006
- 资助金额:
$ 53.04万 - 项目类别:
Optimizing Outcomes Using Suboxone for Opiate Dependence
使用 Suboxone 优化阿片类药物依赖的结果
- 批准号:
7848882 - 财政年份:2006
- 资助金额:
$ 53.04万 - 项目类别:
Optimizing Outcomes Using Suboxone for Opiate Dependence
使用 Suboxone 优化阿片类药物依赖的结果
- 批准号:
7674507 - 财政年份:2006
- 资助金额:
$ 53.04万 - 项目类别:
Optimizing Outcomes Using Suboxone for Opiate Dependence (R01 DA 020210-01)
使用 Suboxone 治疗阿片类药物依赖性优化结果 (R01 DA 020210-01)
- 批准号:
7097067 - 财政年份:2006
- 资助金额:
$ 53.04万 - 项目类别:
Optimizing Outcomes Using Suboxone for Opiate Dependence
使用 Suboxone 优化阿片类药物依赖的结果
- 批准号:
7502046 - 财政年份:2006
- 资助金额:
$ 53.04万 - 项目类别:
EFFECTS OF METHAMPHETAMINE ABUSE ON CEREVRAL GLUCOSE METABOLISM
甲基苯丙胺滥用对脑葡萄糖代谢的影响
- 批准号:
7205342 - 财政年份:2004
- 资助金额:
$ 53.04万 - 项目类别:
相似海外基金
Planning Study for the Development of Sigma 2 ligands as Analgesics
Sigma 2 配体镇痛药开发规划研究
- 批准号:
10641500 - 财政年份:2023
- 资助金额:
$ 53.04万 - 项目类别:
Designing and validating optimal nonaddictive analgesics using the CANDO paradigm
使用 CANDO 范式设计和验证最佳的非成瘾性镇痛药
- 批准号:
10485593 - 财政年份:2023
- 资助金额:
$ 53.04万 - 项目类别:
Identification of botanical hHv1 channel blockers as analgesics for neuropathic pain
植物 hHv1 通道阻滞剂作为神经性疼痛镇痛药的鉴定
- 批准号:
10728526 - 财政年份:2023
- 资助金额:
$ 53.04万 - 项目类别:
Development of LPA5 Antagonists as Analgesics
LPA5 拮抗剂镇痛药的开发
- 批准号:
10638278 - 财政年份:2023
- 资助金额:
$ 53.04万 - 项目类别:
Designed Multiple Ligands as Non-opioid Analgesics for Treating Chronic Pain
设计多种配体作为非阿片类镇痛药,用于治疗慢性疼痛
- 批准号:
10621646 - 财政年份:2023
- 资助金额:
$ 53.04万 - 项目类别:
Elucidation of the mechanism of pain suppression by exercise and development of new analgesics
阐明运动镇痛机制及开发新型镇痛药
- 批准号:
22K19602 - 财政年份:2022
- 资助金额:
$ 53.04万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10425794 - 财政年份:2022
- 资助金额:
$ 53.04万 - 项目类别:
Allosteric Targeting of Cannabinoid CB1 Receptor to Develop Non-Addictive Small Molecule Analgesics
大麻素 CB1 受体变构靶向开发非成瘾性小分子镇痛药
- 批准号:
10512672 - 财政年份:2022
- 资助金额:
$ 53.04万 - 项目类别:
A novel clinically-relevant mouse model of chronic overlapping pain conditions for screening analgesics
用于筛选镇痛药的新型临床相关慢性重叠疼痛小鼠模型
- 批准号:
10821681 - 财政年份:2022
- 资助金额:
$ 53.04万 - 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10721752 - 财政年份:2022
- 资助金额:
$ 53.04万 - 项目类别:














{{item.name}}会员




